Samantha A. Barnes
15 Hospital Ave
Nedlands, WA 6009, Australia
Nedlands, WA 6009, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Interleukin-4 modulates type I interferon to augment antitumor immunity.
Journal: Science advances
Published: May 14, 2025
Type I interferon subtypes differentially activate the anti-leukaemic function of natural killer cells.
Journal: Frontiers in immunology
Published: September 22, 2022
Non-severe burn injury increases cancer incidence in mice and has long-term impacts on the activation and function of T cells.
Journal: Burns & trauma
Published: October 05, 2021
Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies.
Journal: Frontiers in immunology
Published: August 27, 2021
IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies.
Journal: Frontiers in immunology
Published: July 02, 2021
Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV).
Journal: International journal of molecular sciences
Published: October 28, 2020
Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B- and T-cell acute lymphoblastic leukaemia.
Journal: Clinical & translational immunology
Published: January 07, 2020
Diverse Anti-Tumor Immune Potential Driven by Individual IFNα Subtypes.
Journal: Frontiers in immunology
Published: December 12, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026